Trials / Sponsors / Guangzhou Excelmab Inc.
Guangzhou Excelmab Inc.
Industry · 1 registered clinical trial — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Safety and Efficacy of EX103 in Subjects with Relapsed/Refractory CD20-Positive Non-Hodgkin Lymphoma CD20-positive Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | 2021-11-12 |